DSC ADVISORS L P
Q4 2021 Form 13-F
CHICAGO, ILLINOIS
CIK 0001299434
· CRD 158312
· SEC-registered investment adviser
Consolidated report · includes
1 manager
since Q2 2017
$129.4M Reported Value Total
SEC Registered
Discretionary Manager
Private funds (Form ADV)
6 funds
· $483.9M gross asset value
Hedge Fund: $483.9M
Source: Form ADV filed 2020-02-14
Reported value
$129.4M
Quarter over quarter
+8.3%
Holdings
68
Top-10 concentration
72.2%
Filing Structure
Reports holdings for
- DSCQG PR LLC · File #028-18129 · since Q2 2017
- DSCQG PR LLC (not a 13F filer in our records) · Q4 2016 – Q1 2017 · declared by one filing
- DACQG PR LLC (not a 13F filer in our records) · Q3 2016 – Q3 2016 · declared by one filing
- DSC Quantitative Group, LLC (not a 13F filer in our records) · Q2 2013 – Q2 2016 · declared by one filing
Key People
Form ADV owners & control persons
Andrew Gordon Bluhm
PRINCIPAL
Amy Catherine Close
CHIEF COMPLIANCE OFFICER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q4 2021 13F record
Q4 2021 13F filing summary
| Period of report | December 31, 2021 |
|---|---|
| Filed | February 14, 2022 |
| Form | 13F-HR |
| Reported value | $129.4M |
| Positions | 68 |
| Change in reported value | +31.4% |
| New positions | 9 |
| Exited positions | 9 |
| Position turnover | 23.4% |
| Top-10 concentration | 72.2% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2024 13F
Filed Nov 14, 2024
|
19 | $11.0M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
23 | $30.0M |
|
Q1 2024 13F
Filed May 15, 2024
|
30 | $62.6M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
26 | $60.5M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
26 | $77.9M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
25 | $66.7M |
|
Q1 2023 13F
Filed May 15, 2023
|
19 | $114.5M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
15 | $43.5M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
93 | $97.0M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
109 | $100.1M |
|
Q1 2022 13F
Filed May 16, 2022
|
127 | $290.3M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
68 | $129.4M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
68 | $98.5M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
65 | $138.4M |
|
Q1 2021 13F
Filed May 14, 2021
|
75 | $161.4M |
|
Q4 2020 13F
Filed Feb 16, 2021
|
40 | $120.9M |
|
Q3 2020 13F
Filed Nov 16, 2020
|
39 | $149.5M |
|
Q2 2020 13F
Filed Aug 14, 2020
|
29 | $91.2M |
|
Q1 2020 13F
Filed May 15, 2020
|
28 | $102.4M |
|
Q4 2019 13F
Filed Feb 14, 2020
|
79 | $208.7M |
26 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2021
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | QQQ P INVESCO QQQ TR | $39.8M | 30.74% |
| 2 | CVS CVS HEALTH CORP | $11.3M | 8.76% |
| 3 | COR AMERISOURCEBERGEN CORP | $8.6M | 6.67% |
| 4 | GOOG ALPHABET INC | $6.7M | 5.14% |
| 5 | BMRN BIOMARIN PHARMACEUTICAL INC | $6.2M | 4.78% |
| 6 | ATH ATHENE HOLDING LTD | $5.3M | 4.09% |
| 7 | ZBH ZIMMER BIOMET HOLDINGS INC | $5.2M | 3.98% |
| 8 | GBT GLOBAL BLOOD THERAPEUTICS IN | $4.7M | 3.62% |
| 9 | BMRN P BIOMARIN PHARMACEUTICAL INC | $3.1M | 2.39% |
| 10 | VYNE VYNE THERAPEUTICS INC | $2.6M | 2.01% |
| 11 | GOOGL ALPHABET INC | $2.0M | 1.54% |
| 12 | MSFT MICROSOFT CORP | $2.0M | 1.54% |
| 13 | AAPL APPLE INC | $1.8M | 1.42% |
| 14 | META META PLATFORMS INC | $1.8M | 1.36% |
| 15 | AMZN AMAZON COM INC | $1.5M | 1.13% |
| 16 | BRK-B BERKSHIRE HATHAWAY INC DEL | $1.4M | 1.09% |
| 17 | NVDA NVIDIA CORPORATION | $1.2M | 0.94% |
| 18 | EAR EARGO INC | $1.2M | 0.91% |
| 19 | EHTH EHEALTH INC | $1.1M | 0.89% |
| 20 | V VISA INC | $1.1M | 0.86% |
Values as reported on the Q4 2021 Form 13F. Every position is in the holdings table below.